About Hemodialysis Vascular Grafts
The global hemodialysis vascular grafts market is expected to grow in the future due to rising technological advancements and modernization in the healthcare sector, rising research and development activities in the healthcare sector. Hemodialysis is a process that uses an artificial kidney or a dialyzer to clean the blood of the patient. Hemodialysis vascular grafts help to ensure ample blood during the process of hemodialysis. Moreover, these grafts use the connection between the arteries and veins to ensure effective dialysis. The increasing prevalence of renal disorders and the growing adoption of biological access grafts are driving the market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 5.1% |
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hemodialysis Vascular Grafts market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
W. L. Gore & Associates, Inc. (United States), C. R. Bard, Inc. (United States), Terumo Medical (United States), LeMaitre Vascular (United States), Medtronic (Ireland), Getinge AB (Sweden), Vascular Genesis (United States), InnAVasc Medical (United States), CryoLife (United States) and Merit Medical Systems (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Endologix (United States) and Proteon Therapeutics (United States).
Segmentation Overview
AMA Research has segmented the market of Global Hemodialysis Vascular Grafts market by Type (Polyester, Polytetrafluoroethylene, Polyurethane and Biological Materials), Application (Hospitals, Clinics and Others) and Region.
On the basis of geography, the market of Hemodialysis Vascular Grafts has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Raw Material, the sub-segment i.e. Polytetrafluoroethylene will boost the Hemodialysis Vascular Grafts market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indication, the sub-segment i.e. Endovascular Aneurysm Repair will boost the Hemodialysis Vascular Grafts market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological Advancements in Hemodialysis Vascular Grafts
Market Growth Drivers:
Increasing Prevalence of Renal Disorders and Growing Adoption of Biological Access Grafts
Challenges:
Increasing Complications associated with the Prosthetic Grafts
Restraints:
Product Failures and Recalls and High Cost of Treatment
Opportunities:
Growing Need for Development of Innovative and Advanced Vascular Grafts and Rapid Advancement in Health Care Sector
Market Leaders and their expansionary development strategies
On February 22, 2023, Terumo Corporation announced the completion of its acquisition of Carmat, a French company developing a bioprosthetic total artificial heart. Terumo intends to leverage Carmat's expertise in developing new biocompatible materials for cardiovascular applications, which could potentially be applied to hemodialysis vascular grafts.
On October 25, 2023, B. Braun Medical announced the launch of the Exicel AV plus hemodialysis graft in Europe. The Exicel AV plus is a next-generation graft designed to improve patency rates and reduce the risk of complications in hemodialysis patients.
Key Target Audience
Hemodialysis Vascular Grafts Manufacturers, Hemodialysis Vascular Grafts Distributors and Suppliers, Hemodialysis Vascular Grafts International Traders, Research and Development Institutes, Potential Investors, Upstream and Downstream Buyers, Industry Associations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.